Danaher Corporation (DHR)
Quantitative Summary
DeterministicAt 35.5x earnings — a 46% discount to the sector average of 65.2x — DHR is in the lower valuation range. Financial health is average: Piotroski 4/9, Altman Z 3.9. DCF fair value of $45 implies 77% downside based on model assumptions.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedDanaher Corporation presents a fundamental profile characterized by significant capital inefficiency despite respectable profitability margins. The core economic engine is underperforming, as the return on invested capital of 4.6% falls substantially below the weighted average cost of capital of 10.0%, generating a negative spread of -5.3%. This indicates that new investments are currently destroying value rather than creating it. While the DuPont decomposition reveals strong pricing power with net margins at 14.7%, this is offset by low asset turnover of 0.29x and moderate leverage, resulting in an ROE of only 6.9%. Quality metrics further reflect these structural challenges; a Piotroski F-Score of 4/9 signals weak financial momentum, while the Profitability Factor alpha of -10.2% confirms deteriorating returns relative to peers. Although the Altman Z-Score of 4.0 suggests low bankruptcy risk and the Beneish M-Score of -2.56 indicates limited earnings manipulation concerns, the underlying capital allocation efficiency remains a primary constraint on long-term value creation.
Valuation metrics suggest the market is pricing in aggressive growth assumptions that may not align with current operational realities. The stock trades at 38.0x forward P/E, significantly above the sector average of 30.8x, implying high expectations for future expansion. However, a discounted cash flow analysis places fair value at $46, reflecting an implied ten-year free cash flow growth rate of only 14.4%. This creates a substantial valuation gap where current prices imply nearly double-digit upside relative to the DCF model's intrinsic worth, resulting in a calculated downside risk of -75.6% from current levels if those high-growth assumptions prove unfounded. The negative Fama-French alpha of -19.01% reinforces that the stock has underperformed on both size and value dimensions over time, suggesting the premium valuation may be difficult to sustain given the lack of growth factor outperformance.
Risk factors are amplified by recent insider activity and specific style factor weaknesses. Over the past 90 days, insiders have executed net selling totaling $274,575, a signal that often precedes periods of consolidation or value re-rating when management anticipates headwinds. The stock exhibits clear exposure to growth tilt risks with an HML score of -0.164 and profitability drag from the RMW factor at -0.102. These data points collectively highlight a scenario where high valuation multiples are supported by optimistic long-term growth projections, yet current capital returns and insider sentiment suggest potential vulnerability if execution slows or market conditions shift toward value-oriented styles.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 3% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 8.1% | 10.1% | 12.1% |
|---|---|---|---|
| 2% | $57 | $40 | $29 |
| 3% | $68 | $45 | $32 |
| 4% | $84 | $53 | $36 |
Center = base case. Green = >10% upside, Red = >10% downside vs $176.11.
Pre-computed DCF: WACC=10.1%, terminal growth 3%. Fair value $45 (-76.9%). Not investment advice.
Valuation Context
Currently trading 20% below its 5-year average P/E of 47.5x.
Price Chart with Moving Averages
Technical Setup
AI GeneratedThe current technical configuration for Danaher Corporation presents a complex picture regarding institutional positioning, characterized by the intersection of price action and moving average dynamics. With shares trading at $171.12 within the healthcare sector, the proximity to key simple moving averages suggests that larger market participants are currently in a state of consolidation or indecision rather than displaying aggressive directional conviction. The lack of significant volume expansion alongside these price levels often indicates that institutional accumulation or distribution is occurring quietly, potentially waiting for clearer catalysts before committing substantial capital flows. Institutional behavior appears cautious as the stock navigates this equilibrium zone without breaking decisively above resistance or falling below support thresholds defined by recent trend lines. The absence of a sharp divergence between volume spikes and price movements implies that major holders may be rebalancing their portfolios rather than initiating new, large-scale positions in either direction. This pattern frequently precedes a period where larger players assess fundamental shifts before making definitive moves, resulting in the observed sideways volatility. Consequently, the market structure currently reflects a waiting game among sophisticated investors who are monitoring for confirmation of sustained momentum before altering their exposure levels significantly.
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Dividend History
| Date | Amount | Change |
|---|---|---|
| 2026-03-27 | $0.4000 | +25.0% |
| 2025-12-26 | $0.3200 | 0.0% |
| 2025-09-26 | $0.3200 | 0.0% |
| 2025-06-27 | $0.3200 | 0.0% |
| 2025-03-28 | $0.3200 | +18.5% |
| 2024-12-27 | $0.2700 | 0.0% |
| 2024-09-27 | $0.2700 | 0.0% |
| 2024-06-28 | $0.2700 | 0.0% |
| 2024-03-27 | $0.2700 | +12.5% |
| 2023-12-28 | $0.2400 | -11.1% |
| 2023-10-11 | $0.2700 | +12.8% |
| 2023-06-29 | $0.2394 | 0.0% |
Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like MOAT or XLV, the fund manager is mechanically forced to buy or sell DHR shares regardless of Danaher Corporation's individual fundamentals. We estimate $13.8B of passive capital is structurally linked to DHR through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Danaher Corporation to visualize passive redemption contagion across ETFs and collateral stocks.
If Danaher Corporation (DHR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Eli Lilly & Co. (LLY) as the most exposed collateral stock, sharing 2 ETFs with DHR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 27 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
DHR Ownership Dynamics
Passive funds hold 1 in every 9 DHR shares, reducing daily market volatility.
Danaher Corporation (DHR) exerts measurable gravity on the passive index market, currently representing 2.7% of the MOAT (MOAT) and 2.0% of the State Street Health Care Select Sector SPDR ETF (XLV). Across 27 tracked ETFs, approximately 78M shares (11.1% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest DHR Exposure
Float lock-up computed from 27 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
DHR Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Danaher Corporation over the past year sits near $195.73 (11% of 252-day volume). The current price of $176.11 sits 10.0% below the POC — suggesting potential mean-reversion upside if institutional demand reasserts at this level.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
DHR Capital Efficiency
How efficiently does Danaher Corporation convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Danaher Corporation converts 76% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-5.4%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-11 | 16,015 | $171.16 | $2.7M |
| 2026-04-27 | 637 | $177.25 | $112,908.25 |
| 2026-04-24 | 110 | $178.57 | $19,642.7 |
| 2026-04-20 | 391 | $194.75 | $76,147.25 |
| 2026-04-15 | 6 | $198.61 | $1,191.66 |
| 2026-04-10 | 2 | $192.99 | $385.98 |
| 2026-04-06 | 97 | $191.12 | $18,538.64 |
| 2026-03-25 | 63 | $190.10 | $11,976.3 |
| 2026-03-23 | 679 | $189.35 | $128,568.65 |
| 2026-03-05 | 155 | $204.73 | $31,733.15 |
| 2026-03-02 | 5,000 | $210.64 | $1.1M |
| 2026-01-20 | 135 | $235.99 | $31,858.65 |
| 2026-01-06 | 5,520 | $235.36 | $1.3M |
| 2026-01-05 | 6,662 | $230.40 | $1.5M |
| 2025-12-29 | 1 | $230.32 | $230.32 |
| 2025-12-24 | 1,598 | $230.83 | $368,866.34 |
| 2025-12-23 | 1 | $228.01 | $228.01 |
| 2025-12-19 | 1,333 | $224.35 | $299,058.55 |
| 2025-12-18 | 295,579 | $222.63 | $65.8M |
| 2025-12-10 | 81 | $223.23 | $18,081.63 |
| 2025-12-09 | 91 | $224.48 | $20,427.68 |
| 2025-12-02 | 125 | $224.14 | $28,017.5 |
| 2025-11-24 | 1,000 | $227.39 | $227,390 |
| 2025-11-19 | 3 | $225.51 | $676.53 |
| 2025-11-17 | 1,053 | $221.21 | $232,934.13 |
| 2025-11-13 | 764 | $219.40 | $167,621.6 |
| 2025-11-12 | 355 | $215.79 | $76,605.45 |
| 2025-11-10 | 2 | $209.94 | $419.88 |
| 2025-11-07 | 195 | $210.67 | $41,080.65 |
| 2025-11-04 | 1 | $214.06 | $214.06 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| TMO | 0.819 | 0.735 | High co-movement |
| A | 0.784 | 0.693 | High co-movement |
| MTD | 0.765 | 0.699 | High co-movement |
| WAT | 0.669 | 0.489 | Moderate |
| IQV | 0.649 | 0.554 | Moderate |
| PFE | 0.628 | 0.485 | Moderate |
| MRK | 0.571 | 0.352 | Moderate |
| DOV | 0.538 | 0.550 | Moderate |
| GEHC | 0.513 | 0.491 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare DHR to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.